Elixinol Global Limited (ASX: EXL; OTCQB: ELLXF) is a global leader in the hemp-derived CBD industry, researching, developing, marketing and selling Elixinol-branded, hemp-derived full and broad spectrum CBD products.
The company is submitting a Novel Foods application in Europe, expanding its CBD product range across the US given an increasingly favourable regulatory outlook and continuing the growth of its market-leading Hemp Foods Australia brand.
